Magnesium Supplements Lower Blood Sugar in Older Adults with Pre-Diabetes
Four-month study shows magnesium supplementation significantly reduced fasting blood glucose in older Chinese adults with pre-diabetes.
Summary
A four-month study of 71 older Chinese adults with pre-diabetes and low magnesium levels found that daily magnesium supplementation significantly reduced fasting blood sugar compared to placebo. Participants took 360mg of elemental magnesium daily, which corrected their magnesium deficiency and lowered fasting glucose by about 9mg/dL. However, the supplement didn't improve other diabetes markers like HbA1c or insulin resistance. While promising for blood sugar management, the clinical significance of this isolated improvement remains unclear, and researchers emphasize that larger, longer studies are needed to determine if magnesium can actually prevent diabetes progression in this vulnerable population.
Detailed Summary
Pre-diabetes affects millions of older adults and significantly increases risk of developing type 2 diabetes and cardiovascular disease. This condition often coincides with magnesium deficiency, which may worsen blood sugar control, yet evidence for magnesium supplementation in this population has been limited.
Researchers conducted a rigorous four-month, double-blind, placebo-controlled trial with 71 community-dwelling older Chinese adults (average age 69) who had both pre-diabetes and low magnesium levels. Participants received either 360mg of elemental magnesium daily or an identical placebo, with comprehensive metabolic testing throughout the study period.
The results showed magnesium supplementation successfully corrected magnesium deficiency and significantly reduced fasting blood glucose by approximately 9mg/dL compared to placebo. However, the benefits were limited - other important diabetes markers including HbA1c, insulin levels, and insulin resistance showed no significant improvement. Inflammatory markers also remained unchanged between groups.
For longevity and metabolic health, these findings suggest magnesium supplementation may offer modest blood sugar benefits in older adults with deficiency, but the isolated improvement in fasting glucose may not translate to meaningful diabetes prevention. The lack of improvement in HbA1c, which reflects longer-term blood sugar control, is particularly noteworthy.
Important limitations include the relatively small sample size, short duration, and focus on a specific population. The clinical significance of improving only fasting glucose remains uncertain, and researchers acknowledge that larger, longer-term studies are essential to determine whether magnesium supplementation can actually prevent diabetes progression in older adults with pre-diabetes.
Key Findings
- Magnesium supplementation reduced fasting blood glucose by 9mg/dL in older adults with pre-diabetes
- 360mg daily elemental magnesium successfully corrected magnesium deficiency within four months
- No improvements seen in HbA1c, insulin resistance, or inflammatory markers despite glucose benefits
- Benefits were isolated to fasting glucose only, with uncertain clinical significance
Methodology
This was a 4-month, randomized, double-blind, placebo-controlled trial with 71 older Chinese adults (mean age 68.7 years) who had pre-diabetes and hypomagnesemia. Participants received either 360mg elemental magnesium daily or identical placebo, with comprehensive metabolic and inflammatory marker testing.
Study Limitations
The study was relatively small with only 71 participants and lasted just four months, which may be insufficient to detect meaningful changes in diabetes progression markers. Results may not generalize beyond older Chinese adults with both pre-diabetes and confirmed magnesium deficiency.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.